去甲斑蝥酸钠联合肝动脉栓塞化疗术治疗中晚期肝癌的临床研究

去甲斑蝥酸钠联合肝动脉栓塞化疗术治疗中晚期肝癌的临床研
究
徐由锁;孟庆顺;苏峰;赵同壁
【期刊名称】《医学综述》
【年(卷),期】2011(17)13
【摘要】目的观察去甲斑蝥酸钠(SNCTD)联合肝动脉栓塞化疗(TACE)术治疗中晚期肝癌的临床疗效及不良反应.方法选取我院2006年1月至2009年2月收治的128例原发性肝癌患者,随机分为治疗组(SNCTD联合TACE)64例与对照组(单纯TACE)64例,观察两组近期疗效、前3年生存率、治疗前后生活质量卡氏评分(KPS)及不良反应.结果治疗组与对照组治疗前后近期总有效率分别为82.81%、56.25%,治疗组前3年生存率分别为78.13%、65.63%、34.38%.对照组前3年生存率分别为46.88%、32.81%、14.06%,外周血象、生活质量KPS评分值均比治疗前有不同程度的提高,两组间差异均有统计学意义(P＜0.05).结论 SNCTD联合TACE术治疗中晚期肝癌能协同增效,对延长患者的生存时间,改善患者生活质量,降低粒细胞减少的发生方面有一定的临床价值.%Objective To evaluate the clinical efficacy and side effects of the treatment of advanced liver cancer by sodium norcantharidin( SNCTD )combined with transcatheter hepatic arterial chemoembolization( TACE ). Methods 128 patients with primary liver cancer were randomly divided into two groups: one group of
64patients received the treatment of SNCTD combined with TACE and the other 64 patients received the treatment of TACE. The term effect,3-year survival, the chang of quality of life and adverse effect before and after
treatment( KPS score )of the two groups were observed. Results The short-term total effective rate of the treatment group and the control group was 82.81％ and 56.25％ respectively; 3-year survival rate by year of the treatment group was 78.13％ ,65.63％ ,34.38％ respectively; 3-year survival rate by year of the control group was 46.88％ ,32.81％ ,14.06％respectively. After treatment improvement in peripheral blood and life quality ( KPS score )of different degrees were observed with significant difference between the two groups( P ＜ 0.05 ).Conclusion The treatment for advanced liver cancer by SNCTD combined TACE is synergistic; a certain clinical value is seen in the aspect of extending survival
time,improving life quality and reducing the incidence of neutropenia.【总页数】2页(P2058-2059)
【作者】徐由锁;孟庆顺;苏峰;赵同壁
【作者单位】山东省单县中心医院消化科,山东,菏泽,274300;山东省单县中心医院消化科,山东,菏泽,274300;山东省单县中心医院消化科,山东,菏泽,274300;山东省单县中心医院消化科,山东,菏泽,274300
【正文语种】中文
【中图分类】R735.7
【相关文献】
1.重组人血管内皮抑制素联合肝动脉栓塞化疗术治疗中晚期原发性肝癌的临床研究[J], 赵建国;王挺;赵中伟;叶万立;吴东平;纪建松;王建芳;
2.肝动脉介入栓塞化疗联合高强度聚焦超声消融术在中晚期肝癌综合治疗中的应用
效果和安全性分析 [J], 方敏洁;付明生;刘强
3.重组人血管内皮抑制素联合肝动脉栓塞化疗术治疗中晚期原发性肝癌的临床研究[J], 赵建国;王挺;赵中伟;叶万立;吴东平;纪建松;王建芳
4.微波消融联合肝动脉栓塞化疗术治疗中晚期肝癌的临床研究 [J], 程昌盛;牛广林;李绍东;李俊杰;汤伟光;王春清;钟卓桦;吴玉凤;黄献球;吴燕;覃祖云;韦建良
5.抗癌平丸联合肝动脉栓塞化疗术治疗中晚期肝癌临床研究 [J], 陈丽
因版权原因，仅展示原文概要，查看原文内容请购买。